CLL trials in the United kingdom the medical Research council CLL trials 1, 2 and 3

Leukemia and Lymphoma

Volumn 5, Issue S1, 1991, Pages 105-111

  Catovsky, D ^a   Richards, S ^b   Fooks, J ^b   Hamblin, T J ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^c Royal Victoria Hospital   (United Kingdom)

Author keywords

CLL Trials; U.K

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; EPIRUBICIN; PREDNISOLONE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; DRUG RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; SPLEEN; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0026320325     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199109103389     Document Type: Article

References (9)

1. Clinical staging of chronic lymphocytic leukemia
2. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
3. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system
4. The UK Medical Research Council CLL trials 1 and 2
5. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia
6. and participating members of PETHEMA Treatment of chronic lymphocytic leukemia in advanced stages: a randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine and prednisone
7. Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia
8. Vincristine therapy of lymphomas and chronic lymphocytic leukemia
9. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients